September 24, 2008: Evident Technologies Inc. announced the issuance of US Patent No. 7,399,429 covering the ability to make semiconductor nanocrystals from III-V materials, including indium gallium phosphide.
Evident Technologies’ array of semiconductor nanocrystal materials are used in products ranging from electronics to life science reagents. The company says the new patented technology will help companies and research institutes continue the development of quantum dot applications from energy conversion, to LEDs , to life science.
“The unique spectral properties of these III-V quantum dot nanocrystals include absorption in the ultraviolet through the near-infrared range and emission in the near-infrared range, and are ideal for several applications within the life sciences,” said Todd Nelson, CEO of eBioscience, the worldwide exclusive licensee of this technology within the life sciences industry. “We believe our customers will find that the products enabled by this technology will represent a significant advancement in multicolor applications, and will allow us to develop the next generation of eFluor in-vivo imaging reagents.”
“The issuance of this key patent underscores the fact that Evident Technologies remains a pioneer in the development of novel and proprietary semiconductor nanocrystals, and affords us broad protection in a rapidly growing segment of the market,” stated Clint Ballinger, CEO of Evident Technologies.